Health-Economic Consequences of Diabetic Foot Lesions

Tennvall, Gunnel Ragnarson; Apelqvist, Jan
August 2004
Clinical Infectious Diseases;8/1/2004 Supplement, Vol. 39, pS132
Academic Journal
Diabetic foot complications result in huge costs for both society and the individual patients. Few reports on the health-economic consequences of diabetic foot infections have been published. In studies considering a wide societal perspective, costs of antibiotics were relatively low, whereas total costs for topical treatment were high relative to the total costs of foot infections. Total direct costs for healing of infected ulcers not requiring amputation are ∼$17,500 (in 1998 US dollars), whereas the costs for lower-extremity amputations are ∼$30,000-$33,500 depending on the level of amputation. Prevention of foot ulcers and amputations by various methods, including patient education, proper footwear, and foot care, in patients at risk is cost effective or even cost saving. Awareness of the potential influence of reimbursement systems on prevention, management, and outcomes of diabetic foot lesions has increased. Despite methodological obstacles, modeling studies are needed in future health-economic evaluations to determine the cost effectiveness of various strategies.


Related Articles

  • Diabetic foot: Strategies to prevent and treat common problems. Bulat, Tatjana; Kosinski, Mark // Geriatrics;Feb95, Vol. 50 Issue 2, p46 

    Discusses foot ulceration in diabetic patients. Risk factors for diabetic foot ulcers; Guidelines for prevention; Management of ulcers.

  • Manage diabetic foot ulcers with multidisciplinary approach.  // Geriatrics;Jan2000, Vol. 55 Issue 1, p94 

    Presents an abstract of the article `Benefits of a Multidisciplinary Approach in the Management of Recurrent Diabetic Foot Ulceration in Lithuania: A Prospective Study,' by V. Dargis, O. Pantelejeva, et al., which appeared in the September 1999 issue of the periodical `Diabetes Care.'

  • Activity Patterns of Patient With Diabetic Foot Ulceration. Armstrong, David G.; Lavery, Lawrence R.; Kimbriel, Heather R.; Nixon, Brent P.; Boulton, Andrew J. M. // Diabetes Care;Sep2003, Vol. 26 Issue 9, p2595 

    OBJECTIVE — To evaluate the activity of patients with diabetic foot ulcerations and their adherence to their pressure off-loading device. RESEARCH DESIGN AND METHODS — We enrolled 20 subjects treated for neuropathic diabetic foot wounds corresponding to University of Texas grade 1...

  • Diabetic Foot Ulcers: A Guide to Treatment. Phillips, P.; Evans, A.; Popplewell, P. // American Journal of Clinical Dermatology;Mar/Apr2000, Vol. 1 Issue 2, p117 

    Foot ulcers are a major cause of morbidity and impaired quality of life in patients with diabetes mellitus, and they represent a major work load and cost for healthcare systems. This article develops a stepped-care approach (fig. 1), and gives practical guidelines for ulcer preparation, dressing...

  • Impaired healing of neuropathic foot ulcers due to neuropathic bladder distension in a patient with diabetes. Masson, Ewan A.; MacFarlane, Ian A. // BMJ: British Medical Journal (International Edition);8/4/90, Vol. 301 Issue 6746, p281 

    Examines the impaired healing of neuropathic foot ulcers due to neuropathic bladder distension in a patient with diabetes in Great Britain. Causes of foot ulcers; Case of a 69-year old woman with non-insulin dependent diabetes; Importance of ultrasonography in the treatment of patients with...

  • Living Skin Product Improves Foot Ulcer Tx. Talsma, Julia // Dermatology Times;Aug99, Vol. 20 Issue 8, p5 

    Reports on the potential of Apligraf, a living skin construct approved by the United States Food and Drug Administration, to treat diabetic foot ulcers. Healing rate; Number of days needed for complete wound closure; Patient characteristics; Characteristics of ulcers; Features of the skin product.

  • New treatments for lower extremity ulcers. Brown, Anne B. // Patient Care for the Nurse Practitioner;Dec2001, Vol. 4 Issue 12, p9 

    Presents guidelines on the treatment of lower extremity ulcers in diabetic patients. Characteristics to be determined in performing an assessment of ulcers; Therapeutic interventions in treating nonhealing wounds; Methods of debridement which can be used.

  • Incidence, Outcomes, and Cost of Foot Ulcers in Patients with Diabetes. Ramsey, Scott D.; Newton, Katherine; Blough, David; McCulloch, David K.; Sandhu, Nirmala; Reiber, Gayle E.; Wagner, Edward H. // Diabetes Care;Mar1999, Vol. 22 Issue 3, p382 

    Presents a study which determined the incidence of foot ulcers in patients with diabetes, the risk of developing serious complications after diagnosis, and the cost of care compared with that in patients without foot ulcers. Research design and methods; Results; Conclusions.

  • The Use of the Semmes-Weinstein Monofilament and Other Threshold Tests for Preventing Foot Ulceration and Amputation in Persons with Diabetes. Mayfield, Jennifer A.; Sugarman, Jonathan R. // Journal of Family Practice;Nov2000 Supplement, Vol. 49 Issue 11, pS17 

    Focuses on the study on the use of Semmes-Weinstein Monofilament (SWM) and other threshold tests in preventing diabetic foot ulcer and amputation. Characteristics of the SWM as a choice for screening diabetic feet; Management of patients without protective sensation; Role of neuropathy in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics